Update of Serratia marcescens bacteremia associated with contaminated magnesium sulfate

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Friday, April 08, 2005, 18:05 EDT (6:05 PM EDT)
  
  CDCHAN-00226-2005-04-08-UPD-N
  
  In follow-up to the previous notification of S. marcescens bacteremia associated with contaminated magnesium sulfate from PharMEDium (March 18, 2005), the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration have obtained new information in their ongoing investigation. Because evidence exists to implicate at least three contaminated PharMEDium lots of magnesium sulfate, CDC recommends that magnesium sulfate solution from Pharmedium not be administered to patients until the scope of contamination can be determined. PharMEDium is voluntarily recalling all 50 ml. magnesium sulfate admixtures. These 50 ml preparations will not be available until further notice.
  
  
• Subjects:
  Bacteremia Cardiac Surgical Procedures Cardiovascular Agents/adverse Effects Disease Outbreaks Drug Compounding/standards Drug Contamination Magnesium Sulfate/adverse Effects Risk Factors Serratia Infections
• Source:
  HAN ; 226
• Series:
  Health Alert Network
• Document Type:
  HAN Health Update
• Place as Subject:
  United States
• Pages in Document:
  1 unnumbered page
• Issue:
  226
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:8ba9c9192de07ae9f9da06d63f949bc2b815c8f50413cf9ccdaa2c71fdedee1beb2064722e1d1e7ed9f2294b85f0fe4a92b5000666df1519c6e03e5ab08f35a8
• Download URL:
  https://stacks.cdc.gov/view/cdc/25137/cdc_25137_DS1.pdf
• File Type:
  [PDF - 439.77 KB ]